Dry Eye Syndrome Market Revenue 2024 to 2034
Dry Eye Syndrome Market Revenue 2024 to 2034
The dry eye syndrome market, valued at USD 4.03 billion in 2024, is projected to reach USD 8.07 billion by 2034, at 7.2% CAGR, driven by aging populations, digital screen exposure, and improved therapies.
Report ID: 10480
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 4.03 Bn
Forecast Year,
USD 8.07 Bn
CAGR, 2025 -
7.20%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Dry Eye Syndrome Market Size Analysis
Dry Eye Syndrome Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OTC Artificial Tears | 1.61 | 1.73 | 1.86 | 1.99 | 2.14 | 2.30 | 2.47 | 2.65 | 2.84 | 3.05 | 3.27 |
| Prescription Drugs | 2.42 | 2.59 | 2.77 | 2.97 | 3.18 | 3.40 | 3.65 | 3.91 | 4.18 | 4.48 | 4.80 |
Dry Eye Syndrome Market Size By Disease Type 2024 to 2034 (USD )
| Disease Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Evaporative | 2.13 | 2.29 | 2.45 | 2.62 | 2.80 | 3.00 | 3.21 | 3.44 | 3.68 | 3.94 | 4.22 |
| Aqueous-deficient | 1.89 | 2.03 | 2.18 | 2.34 | 2.52 | 2.70 | 2.90 | 3.11 | 3.34 | 3.59 | 3.85 |
Dry Eye Syndrome Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 1.01 | 1.08 | 1.16 | 1.25 | 1.35 | 1.45 | 1.56 | 1.67 | 1.80 | 1.94 | 2.08 |
| Retail Pharmacies | 2.01 | 2.16 | 2.32 | 2.48 | 2.66 | 2.85 | 3.06 | 3.28 | 3.52 | 3.77 | 4.05 |
| Online Pharmacies | 1.01 | 1.08 | 1.15 | 1.23 | 1.31 | 1.40 | 1.50 | 1.60 | 1.71 | 1.82 | 1.94 |
Dry Eye Syndrome Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.53 | 1.63 | 1.74 | 1.86 | 1.98 | 2.12 | 2.26 | 2.41 | 2.57 | 2.74 | 2.93 |
| Europe | 1.01 | 1.07 | 1.14 | 1.22 | 1.30 | 1.38 | 1.47 | 1.57 | 1.67 | 1.78 | 1.90 |
| Asia Pacific | 1.09 | 1.17 | 1.26 | 1.35 | 1.45 | 1.56 | 1.67 | 1.80 | 1.93 | 2.07 | 2.23 |
| Latin America | 0.20 | 0.23 | 0.26 | 0.29 | 0.32 | 0.36 | 0.40 | 0.45 | 0.50 | 0.55 | 0.61 |
| Middle East & Africa | 0.20 | 0.22 | 0.23 | 0.25 | 0.27 | 0.29 | 0.31 | 0.33 | 0.36 | 0.38 | 0.41 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
